Your browser doesn't support javascript.
loading
Pathway-specific engineered mouse allograft models functionally recapitulate human serous epithelial ovarian cancer.
Szabova, Ludmila; Bupp, Sujata; Kamal, Muhaymin; Householder, Deborah B; Hernandez, Lidia; Schlomer, Jerome J; Baran, Maureen L; Yi, Ming; Stephens, Robert M; Annunziata, Christina M; Martin, Philip L; Van Dyke, Terry A; Weaver Ohler, Zoe; Difilippantonio, Simone.
Affiliation
  • Szabova L; Center for Advanced Preclinical Research, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Bupp S; Center for Advanced Preclinical Research, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Kamal M; Center for Advanced Preclinical Research, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Householder DB; Center for Advanced Preclinical Research, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Hernandez L; Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Schlomer JJ; Center for Advanced Preclinical Research, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Baran ML; Center for Advanced Preclinical Research, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Yi M; Advanced Biomedical Computing Center, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Stephens RM; Advanced Biomedical Computing Center, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Annunziata CM; Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland, United States of America.
  • Martin PL; Center for Advanced Preclinical Research, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Van Dyke TA; Center for Advanced Preclinical Research, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America; Mouse Cancer Genetics Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of Americ
  • Weaver Ohler Z; Center for Advanced Preclinical Research, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Difilippantonio S; Center for Advanced Preclinical Research, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
PLoS One ; 9(4): e95649, 2014.
Article in En | MEDLINE | ID: mdl-24748377

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Cystadenocarcinoma, Serous / Neoplasms, Glandular and Epithelial Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2014 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Cystadenocarcinoma, Serous / Neoplasms, Glandular and Epithelial Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2014 Type: Article Affiliation country: United States